NCT02324231View on ClinicalTrials.gov

SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia

NACompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

September 15, 2018

Study Completion Date

September 15, 2018

Conditions
CancerPediatricsFeverNeutropeniaFever in Neutropenia
Interventions
OTHER

39.0°C temperature limit defining fever

Diagnosis of FN, correspondingly hospitalization and start of empirical intravenous broad-spectrum antimicrobial therapy. Further treatment according to treating physician.

OTHER

38.5°C temperature limit defining fever

Diagnosis of FN, correspondingly hospitalization and start of empirical intravenous broad-spectrum antimicrobial therapy. Further treatment according to treating physician.

Trial Locations (6)

CH-4031

Basel: Universitätskinderklinik beider Basel, Basel

CH-3010

Bern: Universitätsklinik für Kinderheilkunde, Inselspital, Bern

CH-1211

Geneva: Département de Pédiatrie, Hôpital Cantonal de Genève, Geneva

CH-1011

Lausanne: Hémato-Oncologie Pédiatrique, CHUV, Lausanne

CH-6000

Luzern: Pädiatrische Hämatologie/Onkologie, Kinderspital, Lucerne

CH-8032

Zürich: Pädiatrische Onkologie Kinderspital, Zurich

All Listed Sponsors
lead

Swiss Pediatric Oncology Group

OTHER

NCT02324231 - SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit Defining Fever in Pediatric Patients With Cancer at Risk for Fever in Chemotherapy-induced Neutropenia | Biotech Hunter | Biotech Hunter